In 1864 was created Societe Generale, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the Paris. The venture was found in Europe in France.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are Software, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Symphony Communication Services Holdings, Talan, QSecure.
Speaking about the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. This Societe Generale works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of more than 100 millions dollars are the general things for fund. The top amount of exits for fund were in 2018. When the investment is from Societe Generale the average startup value is 100-500 millions dollars. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Societe Generale, startups are often financed by Worldview Technology Partners, Redpoint, AllegisCyber. The meaningful sponsors for the fund in investment in the same round are BNP Paribas Private Equity, Citigroup, Worldview Technology Partners. In the next rounds fund is usually obtained by Worldview Technology Partners, UMC Capital, AllegisCyber.
Funds with similar focus
|BonVenture||Bayern, Germany, Munich|
|Charitable Leadership Foundation||Clifton Park, New York, United States|
|Chongqing Dongzheng Huaixin Guquan Touzi Jijin Hehuo Qiye (Youxian Hehuo)||China, Chongqing, Jiulongpo|
|Corner Ventures||California, Palo Alto, United States|
|Delphi VC||New York, New York, United States|
|EDS-A.T. Kearney Ventures||-|
|Guangdong Hongmi Touzi Hehuo Qiye (Putong Hehuo)||China, Guangdong, Zhangshan|
|Invest In Visions||-|
|MF Private Capital||Boston, Massachusetts, United States|
|ODDO BHF||France, Ile-de-France, Paris|
|Opium Ventures||China, Hong Kong, Hong Kong Island|
|Pappas Capital||Durham, North Carolina, United States|
|Ruian Real Estate Development Management||China, Shanghai|
|Ruihuide Keji Touzi||Beijing, Beijing, China|
|Saviu Ventures||Ebène, Mauritius, Plaines Wilhems|
|Shinhan Capital||Seoul, Seoul-t'ukpyolsi, South Korea|
|Sylvain & CO||-|
|Yajie Shanghui||Beijing, China, Haidian|
|$123M||02 Mar 2023||Gurugram, Haryana, India|
|$98M||07 Feb 2023||Chicago, Illinois, United States|
|$267M||18 Jan 2023||London, England, United Kingdom|
|$12M||15 Dec 2022||Paris, Ile-de-France, France|
|$88M||13 Dec 2022||Paris, Ile-de-France, France|
|$44M||22 Nov 2022||Mumbai, Maharashtra, India|
|$580M||14 Nov 2022||London, England, United Kingdom|
|$30M||03 Nov 2022||Paris, Ile-de-France, France|
H2 Green Steel
|$4B||24 Oct 2022||-|
– Provepharm Life Solutions, a Marseille-based pharmaceutical company that finds new applications for known molecules.
– The company raised €120M in funding.
– Tikehau Capital will provide the funds joining the group’s pool of banking investors, including Société Générale, BNP Paribas, Banque Populaire Méditerranée, Crédit Agricole Alpes Provence and Bpifrance.
– The new investment will be used to consolidate its position as an international and independent pharmaceutical group, specifically by hiring new staff in France and the United States, and increasing the size of its laboratories in Marseille.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.